Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,410.00    20.00 (0.84%)
Bid:
2,408.00
Ask:
2,412.00
Spread: 4.00 (0.166%)
Market Cap: £7.74b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

15 Jun 2020 07:00

RNS Number : 8866P
Bunzl PLC
15 June 2020
 

15 June 2020

 

BUNZL PRE CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the six months ending 30 June 2020.

 

Commenting on the Company's response to the COVID-19 pandemic, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"In these unprecedented times, I have continued to be immensely impressed by, and proud of, the dedication and resourcefulness shown by our employees throughout our business in responding to the challenging circumstances presented by the COVID-19 crisis. Everyone, from our delivery drivers and warehouse staff to the expert sales people and customer service specialists, has worked tirelessly to ensure that we have been able to meet the urgent needs of our customers and frontline healthcare workers and support them in the supply of critical products required to fight the impact of the virus."

 

Our ability to respond quickly and effectively to such demands has been underpinned by the strength of our supply chain and our reliable, added-value sourcing operation in Shanghai which together have given our customers the confidence to trust their business with us."

 

The Group's resilient business model is expected to deliver a strong performance in the half year against the background of challenging trading conditions due to the COVID-19 pandemic. Revenue is expected to increase by approximately 6% at both actual and constant exchange rates. After adjusting for the impact of the number of trading days in the period relative to the prior year, at constant exchange rates revenue is expected to rise by approximately 5% as a result of an increase in underlying revenue of approximately 2% and an increase of approximately 3% as a result of recent acquisitions. Due to a change in mix of products sold during the period, including a higher proportion of imported own brand products, overall operating margin is expected to be modestly higher than the comparable period last year.

 

The trading performance is expected to benefit significantly from the breadth of the customer sectors and geographies the Group operates in and the wide range of products supplied. The recent substantial declines in profitability in the lower margin foodservice and retail sectors are expected to be more than offset by strong performances in the grocery and generally higher margin safety, cleaning & hygiene and healthcare sectors, primarily driven by significant sales volumes of COVID-19 related products. The Group, aided by the extensive knowledge and experience of Bunzl's reliable, added-value sourcing operation in Shanghai, has helped healthcare providers and other customers to build their stock levels of key and essential products needed to support their response to the pandemic.

At constant exchange rates revenue growth is expected to be particularly strong in both Continental Europe and Rest of the World driven by demand for COVID-19 related products while North America and UK & Ireland are expected to see slight increases in revenue.

 

As a result of the better than expected trading performance, the Company intends to repay employee-related government support packages and bring forward the settlement of tax deferrals where possible to do so.

 

As highlighted in the first quarter trading statement in April, it is not possible to assess with any certainty the impact that the COVID-19 crisis will have on the Group's performance for the year due to the lack of visibility of how the virus might affect trading conditions during the second half of the year. The Company remains cautious about the outlook given the risks and uncertainties associated with the emergence of global economies from lockdown and the timing of recovery of the Group's markets in the second half, particularly as the volume of orders for COVID-related products seen during the first half is not expected to be repeated with many customers having already built significant stocks of products for the remainder of the year. Specifically, while sectors such as retail and foodservice are expected to continue to be affected by reduced, albeit improving, demand, those parts of Bunzl supplying the grocery, cleaning & hygiene and healthcare sectors are expected to deliver a resilient performance, with a potentially mixed trading performance from the safety sector.

 

There has been no significant change in Bunzl's financial position during the first half and the Company continues to have substantial funding headroom available with strong cashflows and a robust balance sheet.

 

This announcement contains inside information.

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBSGDLUDBDGGS
Date   Source Headline
7th Jul 20219:30 amRNSDirector/PDMR Shareholding
1st Jul 202112:30 pmRNSTotal Voting Rights
24th Jun 20217:00 amRNSTrading Statement
23rd Jun 20218:00 amRNSAdditional Listing
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
1st Jun 20211:00 pmRNSTotal Voting Rights
26th May 20219:30 amRNSDirector Declaration
26th May 20218:00 amRNSAdditional Listing
18th May 20217:00 amRNSAcquisition
6th May 202110:40 amRNSDirector/PDMR Shareholding
5th May 20211:15 pmRNSDirector/PDMR Shareholding
5th May 20211:01 pmRNSDirector/PDMR Shareholding
4th May 202110:50 amRNSTotal Voting Rights
4th May 20219:25 amRNSBlock listing Interim Review
22nd Apr 20214:40 pmRNSDirector/PDMR Shareholding
21st Apr 20214:16 pmRNSResult of AGM
21st Apr 20217:00 amRNSTrading Statement
14th Apr 202111:45 amRNSDirector/PDMR Shareholding
12th Apr 20218:43 amRNSDirector/PDMR Shareholding
12th Apr 20218:24 amRNSDirector/PDMR Shareholding
7th Apr 20213:24 pmRNSDirector/PDMR Shareholding
1st Apr 202111:44 amRNSTotal Voting Rights
31st Mar 20215:34 pmRNSDirector/PDMR Shareholding
22nd Mar 20214:30 pmRNSDirector Declaration
17th Mar 20214:27 pmRNSAnnual Financial Report
8th Mar 20215:53 pmRNSDirector/PDMR Shareholding
5th Mar 20211:10 pmRNSDirector/PDMR Shareholding
4th Mar 20215:33 pmRNSDirector/PDMR Shareholding
3rd Mar 202110:00 amRNSDirector Declaration
1st Mar 20212:00 pmRNSTotal Voting Rights
1st Mar 20211:00 pmRNSDirector/PDMR Shareholding
1st Mar 20211:00 pmRNSDividend Declaration
1st Mar 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSAcquisition
1st Feb 202110:00 amRNSTotal Voting Rights
20th Jan 20217:00 amRNSDirector Declaration
6th Jan 20214:00 pmRNSDirector/PDMR Shareholding
4th Jan 202111:50 amRNSTotal Voting Rights
22nd Dec 20207:00 amRNSDirectorate Change
16th Dec 20208:00 amRNSAdditional Listing
16th Dec 20207:00 amRNSTrading Statement
9th Dec 20208:00 amRNSAdditional Listing
3rd Dec 20209:27 amRNSDirector/PDMR Shareholding
2nd Dec 20208:00 amRNSAdditional Listing
1st Dec 202011:57 amRNSTotal Voting Rights
20th Nov 202012:30 pmRNSDirector Declaration
9th Nov 20207:00 amRNSAcquisition
3rd Nov 20205:18 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:45 amRNSTotal Voting Rights
2nd Nov 202010:25 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.